CIP
CLB icon

Champlain Investment Partners’s Core Laboratories CLB Stock Holding History

Champlain Investment Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-485,406
Closed -$49.2M – 113
2017
Q2 		$49.2M Buy
485,406
+6,636
+1% +$715K 0.6% 72
2017
Q1 		$55.3M Buy
478,770
+44,735
+10% +$5.2M 0.73% 65
2016
Q4 		$52.1M Buy
434,035
+48,690
+13% +$5.39M 0.72% 62
2016
Q3 		$43.3M Buy
385,345
+50,135
+15% +$5.77M 0.66% 68
2016
Q2 		$41.5M Sell
335,210
-33,715
-9% -$4.07M 0.72% 62
2016
Q1 		$41.5M Buy
368,925
+33,085
+10% +$3.44M 0.75% 55
2015
Q4 		$36.5M Sell
335,840
-15,720
-4% -$1.8M 0.62% 69
2015
Q3 		$35.1M Buy
351,560
+6,475
+2% +$704K 0.61% 73
2015
Q2 		$39.4M Buy
345,085
+57,420
+20% +$6.96M 0.62% 73
2015
Q1 		$30.1M Sell
287,665
-79,690
-22% -$8.49M 0.51% 87
2014
Q4 		$44.2M Buy
367,355
+100,185
+37% +$13.2M 0.7% 65
2014
Q3 		$39.1M Buy
+267,170
New +$41.2M 0.68% 66

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Champlain Investment Partners's CLB Position: Q3 2017 in Review

Champlain Investment Partners sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 485,406 shares — an estimated $49.2M sold.

Champlain Investment Partners first reported a position in CLB in Q3 2014 and held it in 12 quarters. The position peaked at $55.3M in Q1 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Champlain Investment Partners reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Champlain Investment Partners sold 485,406 Core Laboratories shares in Q3 2017, an estimated $49.2M.
  • Champlain Investment Partners first reported a position in Core Laboratories in Q3 2014 and held it in 12 quarters.
  • Champlain Investment Partners's Core Laboratories position peaked at $55.3M in Q1 2017.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Champlain Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.